Purchase Order 75N94021P00704

This is a $20,960 fixed-price purchase order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to the JAI Research Foundation, a non-profit organization. The contract is for solubility, stability, and toxicology studies to advance novel drug candidates developed by the NIDDK into clinical trials. This contract was awarded on September 25, 2020 and has a completion date of September 24, 2021. The contract stems from a small...

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $88,000 firm fixed price purchase order to Frontage Laboratories, Inc., a full-service contract research organization, to provide specialized pharmacokinetic and metabolism research services. The contract supports NIDDK's efforts to advance the testing of a new class of antiviral molecules by conducting blood stability studies, rat and mouse pharmacokinetic studies, and in vitro hepatocyte metabolism studies...

This is a firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH), to Frontage Laboratories, Inc. for $126,850.00. The contract is for research services related to the "Blood Stability and Metabolism of MTS-IV-39 Analogs." This work supports NIDDK's research program and was not set aside for any specific business category. Frontage Laboratories is a full-service contract...

This firm fixed-price purchase order was awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to Cyprotex US LLC, a foreign-owned for-profit contract research organization. The $157,158 contract is for the characterization of absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties of small-molecule drug candidates using standardized in vitro methods. This work supports...

The National Institutes of Health (NIH), an agency of the Department of Health and Human Services, awarded an $11,000 firm fixed price delivery order to Societal Cdmo San Diego, LLC for stability studies required by Good Manufacturing Practices for a finished pharmaceutical product containing mithramycin lyophilized powder for injection. The delivery order was issued against the prime contractor's master indefinite-delivery/indefinite-quantity contract vehicle known as the Drug Formulation and...

This is a $3,358,776 cost-plus-fixed-fee Delivery Order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to PPD Development LP, a global contract research organization (CRO). The award is for a Phase I randomized, double-blind, placebo-controlled study to assess the safety, tolerability, and pharmacokinetics of a medical product. The contract is a task order under NIDA's "Phase I Clinical Trials for Development of Neurotherapeutics" Indefinite...

The National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $90,000.00 firm fixed price purchase order contract to Frontage Laboratories, Inc. for the synthesis of thyclotides (R,R). The contract has no set-aside designation and was awarded on August 14, 2022 with an ultimate completion date of August 17, 2023. Frontage Laboratories, a minority-owned, Asian-Pacific American manufacturer of goods, has provided a range of research...

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the U.S. Department of Health and Human Services, awarded a $16,000 firm-fixed-price purchase order to Imquest Biosciences, Inc., a for-profit preclinical contract research and development organization, for "NIDDK - HIV CYTOPROTECTION ASSAYS 16 COMPOUNDS." The contract has an ultimate completion date of August 31, 2023, and was not set aside for any specific business categories....

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $21,486.10 firm fixed-price purchase order contract to Life Chemicals USA, Inc., a self-certified small disadvantaged business, for an "ION CHANNEL SCREENING LIBRARY" with a completion date of July 31, 2023. The contract does not have a set-aside designation. Based on the agency name, this award is likely associated with NIDDK's research activities related to diabetes, digestive, and kidney...

The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $114,365 firm fixed price purchase order to Labcorp Early Development Laboratories Inc. to complete the pharmacokinetics portion of the Phase 1 RR-HNK study. Labcorp Early Development Laboratories, a subsidiary of Laboratory Corporation of America Holdings, will perform the work over a two-year period from July 2023 through June 2025 at its facility in Madison,...